<!DOCTYPE html><html><head><title>End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) patient-months who were on ESRD treatment for 91 days or more and dialyzed greater than 2 and less than 4 times weekly whose delivered dose of hemodialysis (calculated from the last measurements of the month using the UKM or Daugirdas II formula) was a spKt/V greater than or equal to 1.2 during the study period.</title><link rel="stylesheet" type="text/css" href="style.css"></head><body><div class='section'>
<h2>General
</h2>
<div class='field field_text'>
<h3>
Title
</h3>
<div class='FieldValue'>
<div class="content_title">End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) patient-months who were on ESRD treatment for 91 days or more and dialyzed greater than 2 and less than 4 times weekly whose delivered dose of hemodialysis (calculated from the last measurements of the month using the UKM or Daugirdas II formula) was a spKt/V greater than or equal to 1.2 during the study period.</div>
</div>

</div>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Centers for Medicare & Medicaid Services (CMS). CMS ESRD measures manual for the 2017 performance period: final. Version 2.5. Baltimore (MD): Centers for Medicare & Medicaid Services (CMS); 2017 Oct 11. 168 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Measure Domain
</h2>
<div class='field field_picklist-one'>
<h3>
Primary Measure Domain
</h3>
<div class='FieldValue'>
Clinical Quality Measures: Outcome
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Secondary Measure Domain
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>

</div>
<div class='section'>
<h2>Brief Abstract
</h2>
<div class='field field_text'>
<h3>
Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure is used to assess the percentage of all adult (greater than or equal to 18 years old) patient-months in the sample for analysis who were on end stage renal disease (ESRD) treatment for 91 days or more and dialyzed greater than 2 and less than 4 times weekly whose delivered dose of hemodialysis (calculated from the last measurements of the month using the Urea Kinetic Modeling [UKM] or Daugirdas II formula) was a single pool (sp)Kt/V greater than or equal to 1.2 during the study period.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Rationale
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The dose of dialysis is used to estimate the ability of hemodialysis to clear the blood of accumulated toxins. In the adult population, outcome studies have shown an association between dose of hemodialysis in terms of small solute removal and clinical outcomes (Lowrie et al., 1981; Owen et al., 1993). In addition, at least one prior study demonstrates that a change in dialysis dose is associated with a change in patient outcome (Wolfe et al., 2005). Furthermore, studies demonstrate an association between dialysis adequacy as measured by Kt/V and outcomes (Wolfe et al., 2000; Port et al., 2002; Port et al., 2004). Also, although higher dialysis dose is associated with improvement in clinical outcomes, analysis of CROWNWeb data from January 2010 indicates that only 66% of facilities had 70% or more of their patients receiving a dialysis dose of spKt/V of 1.2.</p></div>
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence for Rationale
</h3>
<div class='FieldValue'>
<table><tr><td>Centers for Medicare & Medicaid Services (CMS). CMS ESRD measures manual for the 2017 performance period: final. Version 2.5. Baltimore (MD): Centers for Medicare & Medicaid Services (CMS); 2017 Oct 11. 168 p. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med. 1981 Nov 12;305(20):1176-81. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=7027040" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993 Sep 30;329(14):1001-6. [25 references] <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8366899" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol. 2002 Apr;13(4):1061-6. [31 references] <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11912267" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Port FK, Wolfe RA, Hulbert-Shearon TE, McCullough KP, Ashby VB, Held PJ. High dialysis dose is associated with lower mortality among women but not among men. Am J Kidney Dis. 2004 Jun;43(6):1014-23. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15168381" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK. Body size, dose of hemodialysis, and mortality. Am J Kidney Dis. 2000 Jan;35(1):80-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10620548 " target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Wolfe RA, Hulbert-Shearon TE, Ashby VB, Mahadevan S, Port FK. Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002. Am J Kidney Dis. 2005 Jan;45(1):127-35. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15696452" target="_blank">PubMed</a></td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Primary Health Components
</h3>
<div class='FieldValue'>
<div class="content_para"><p>End stage renal disease (ERSD); hemodialysis (HD); single pool (sp)Kt/V dose</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>All patient-months for adult (greater than or equal to 18 years old) patients in the sample for analysis who have had end stage renal disease (ESRD) for 91 days or more and dialyzing greater than 2 and less than 4 times weekly the entire month (see the related "Denominator Inclusions/Exclusions" field)</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Number of patient-months in denominator whose delivered dose of hemodialysis (calculated from the last measurements of the month using the Urea Kinetic Modeling [UKM] or Daugirdas II formula) was a single pool (sp)Kt/V greater than or equal to 1.2 and also in range (Kt/V less than or equal to 5.0)</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Evidence Supporting the Measure
</h2>
<div class='field field_picklist-choice'>
<h3>
Type of Evidence Supporting the Criterion of Quality for the Measure
</h3>
<div class='FieldValue'>
A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence
</div>
<div class='FieldValue'>
One or more research studies published in a National Library of Medicine (NLM) indexed, peer-reviewed journal
</div>

</div>
<div class='field field_text'>
<h3>
Additional Information Supporting Need for the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Extent of Measure Testing
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Reliability Testing </strong></p>
<p><em>Method of Reliability Testing</em></p>
<p>The developer used January 2013&ndash;December 2013 CROWNWeb and Medicare Claims data to calculate the inter-unit reliability (IUR) for the overall 12 months to assess the reliability of this measure. The National Quality Forum (NQF)-recommended approach for determining measure reliability is a one-way analysis of variance (ANOVA), in which the between and within facility variation in the measure is determined. The IUR measures the proportion of the measure variability that is attributable to the between-facility variance. The yearly based IUR was estimated using a bootstrap approach, which uses a resampling scheme to estimate the within facility variation that cannot be directly estimated by ANOVA. The developer notes that the method for calculating the IUR was developed for measures that are approximately normally distributed across facilities. Since this measure is not normally distributed, the IUR value should be interpreted with some caution.</p>
<p><em>Statistical Results from Reliability Testing</em></p>
<p>For reliability the developer calculated the monthly and annual IUR across the 12 reporting months. As explained above, the method for calculating the IUR was developed for measures that are approximately normally distributed across facilities. The IUR is 0.942, which is high and suggests 94% of variation in the measure is attributed to between facility variation and approximately 6% attributed to within facility variation. The 95% confidence interval is (0.940, 0.944). </p>
<p><em>Interpretation</em></p>
<p>The IUR suggests this measure is reliable. However, since the distribution of performance scores is skewed, the IUR value should be interpreted with some caution. </p>
<p><strong>Validity Testing</strong></p>
<p><em>Method of Validity Testing</em></p>
<p>Validity was assessed using Spearman correlations to measure the association between facility level performance scores and the 2013 standardized mortality ratio (SMR) (NQF 0369) and standardized hospitalization ratio (SHR) (NQF 1463). </p>
<p>This measure is also established on the basis of face validity. The measure has been reviewed and approved by clinical technical expert panels (TEPs). The individual measures are also NQF endorsed. Achieving target Kt/V is included in the End-stage Renal Disease (ESRD) Quality Incentive Program (QIP) beginning with program year (PY) 2015, and has been reported on Dialysis Facility Compare (DFC) since January 2013.</p>
<p><em>Statistical Results from Validity Testing</em></p>
<p>The Spearman correlation between the HD Kt/V measure and SMR is -0.085, and statistically significant (p less than 0.0001). </p>
<p>The Spearman correlation between HD Kt/V measure and SHR is -0.160, statistically significant (p less than 0.0001). </p>
<p><em>Interpretation</em></p>
<p>The Spearman correlation coefficients indicate higher facility level percentages of patients that achieve the Kt/V target is associated lower standardized mortality and hospitalization, respectively, although the magnitude of the association is low. </p></div>
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence for Extent of Measure Testing
</h3>
<div class='FieldValue'>
<table><tr><td>National Quality Forum measure information: delivered dose of hemodialysis above minimum. Washington (DC): National Quality Forum (NQF); 2016 Dec 23. various p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>State of Use of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
State of Use
</h3>
<div class='FieldValue'>
Current routine use
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Current Use
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Application of the Measure in its Current Use
</h2>
<div class='field field_picklist-choice'>
<h3>
Measurement Setting
</h3>
<div class='FieldValue'>
Ambulatory Procedure/Imaging Center
</div>
<div class='FieldValue'>
Hospital Outpatient
</div>
<div class='FieldValue'>
Managed Care Plans
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Professionals Involved in Delivery of Health Services
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Least Aggregated Level of Services Delivery Addressed
</h3>
<div class='FieldValue'>
Single Health Care Delivery or Public Health Organizations
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Statement of Acceptable Minimum Sample Size
</h3>
<div class='FieldValue'>
Specified
</div>

</div>
<div class='field field_text'>
<h3>
Target Population Age
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Age greater than or equal to 18 years</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Target Population Gender
</h3>
<div class='FieldValue'>
Either male or female
</div>

</div>

</div>
<div class='section'>
<h2>National Strategy for Quality Improvement in Health Care
</h2>
<div class='field field_text'>
<h3>
National Quality Strategy Aim
</h3>
<div class='FieldValue'>
<ul><li>Better Care</li></ul>
</div>

</div>
<div class='field field_text'>
<h3>
National Quality Strategy Priority
</h3>
<div class='FieldValue'>
<ul><li>Prevention and Treatment of Leading Causes of Mortality</li></ul>
</div>

</div>

</div>
<div class='section'>
<h2>Institute of Medicine (IOM) National Health Care Quality Report Categories
</h2>
<div class='field field_picklist-choice'>
<h3>
IOM Care Need
</h3>
<div class='FieldValue'>
Living with Illness
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
IOM Domain
</h3>
<div class='FieldValue'>
Effectiveness
</div>

</div>

</div>
<div class='section'>
<h2>Data Collection for the Measure
</h2>
<div class='field field_text'>
<h3>
Case Finding Period
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The reporting period</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Denominator Sampling Frame
</h3>
<div class='FieldValue'>
Patients associated with provider
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Denominator (Index) Event or Characteristic
</h3>
<div class='FieldValue'>
Clinical Condition
</div>
<div class='FieldValue'>
Patient/Individual (Consumer) Characteristic
</div>
<div class='FieldValue'>
Therapeutic Intervention
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Denominator Time Window
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
All patient-months for adult (greater than or equal to 18 years old) patients in the sample for analysis who have had end stage renal disease (ESRD) for 91 days or more and dialyzing greater than 2 and less than 4 times weekly the entire month</p>
<p class="Note"><strong>Note</strong>: </p>
<ul class="Note" style="list-style-type: disc;">
    <li>A patient may only be assigned to one dialysis facility each month. </li>
    <li>If selected Kt/V value is missing or not in the valid range (greater than 5.0), include patient-month in the denominator but not the numerator. </li>
    <li>If selected Kt/V value is in the valid range (less than or equal to 5.0) and meets the Kt/V value threshold (greater than or equal to 1.2), then include patient-month in denominator and numerator. </li>
</ul>
<p class="Note">Refer to the original measure documentation for additional details.</p>
<p><strong>Exclusions</strong></p>
<ul style="list-style-type: disc;">
    <li>Patients not assigned to the facility for the entire month </li>
    <li>Patients younger than 18 years old as of the first day of the month </li>
    <li>Patients not on hemodialysis the entire month </li>
    <li>Patients who were on ESRD treatment for less than 91 days as of the first of the month </li>
    <li>Patients not dialyzing greater than 2 and less than 4 times weekly
    <ul style="list-style-type: disc;">
        <li>If the patient is identified as not dialyzing greater than 2 and less than 4 times weekly anytime during the month, then the entire patient-month is excluded from the calculations. See the original measure documentation for more details regarding the determination of weekly and frequent dialysis. </li>
    </ul>
    </li>
</ul></div>
</div>

</div>
<div class='field field_picklist-choice-4'>
<h3>
Exclusions/Exceptions
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
Number of patient-months in denominator whose delivered dose of hemodialysis (calculated from the last measurements of the month using the Urea Kinetic Modeling [UKM] or Daugirdas II formula) was a spKt/V greater than or equal to 1.2 and also in range (spKt/V less than or equal to 5.0)</p>
<p><strong>Exclusions</strong><br />
Unspecified</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Numerator Search Strategy
</h3>
<div class='FieldValue'>
Fixed time period or point in time
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Data Source
</h3>
<div class='FieldValue'>
Administrative clinical data
</div>
<div class='FieldValue'>
Electronic health/medical record
</div>
<div class='FieldValue'>
Registry data
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Type of Health State
</h3>
<div class='FieldValue'>
Physiologic Health State (Intermediate Outcome)
</div>

</div>
<div class='field field_text'>
<h3>
Instruments Used and/or Associated with the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Computation of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
Measure Specifies Disaggregation
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Scoring
</h3>
<div class='FieldValue'>
Rate/Proportion
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Interpretation of Score
</h3>
<div class='FieldValue'>
Desired value is a higher score
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Allowance for Patient or Population Factors
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Standard of Comparison
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Identifying Information
</h2>
<div class='field field_text'>
<h3>
Original Title
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Delivered dose of hemodialysis above minimum.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Collection Name
</h3>
<div class='FieldValue'>
End Stage Renal Disease (ESRD) Quality Measures
</div>

</div>
<div class='field field_orglist'>
<h3>
Submitter
</h3>
<div class='FieldValue'>
Centers for Medicare & Medicaid Services - Federal Government Agency [U.S.]
</div>

</div>
<div class='field field_orglist-p'>
<h3>
Developer
</h3>
<div class='FieldValue'>
Centers for Medicare & Medicaid Services - Federal Government Agency [U.S.]
</div>

</div>
<div class='field field_text'>
<h3>
Funding Source(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Centers for Medicare &amp; Medicaid Services (CMS)</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Composition of the Group that Developed the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The University of Michigan Kidney and Epidemiology Cost Center (UM-KECC), develops, maintains, and updates the End Stage Renal Disease (ESRD) Quality Measures for the Centers for Medicare and Medicaid Services (CMS), under the Quality Measure Development and Maintenance contract with CMS. In addition, UM-KECC works with CMS's Measures Management System (MMS) in the development, evaluation, and reporting of the current ESRD Quality Measures.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Financial Disclosures/Other Potential Conflicts of Interest
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_orglist'>
<h3>
Endorser
</h3>
<div class='FieldValue'>
National Quality Forum - None
</div>

</div>
<div class='field field_plain-text'>
<h3>
NQF Number
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Date of Endorsement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>2015 Oct 2</p></div>
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Measure Initiative(s)
</h3>
<div class='FieldValue'>
Dialysis Facility Compare (DFC)
</div>

</div>
<div class='field field_text'>
<h3>
Adaptation
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure was not adapted from another source.</p></div>
</div>

</div>
<div class='field field_date'>
<h3>
Date of Most Current Version in NQMC
</h3>
<div class='FieldValue'>
2017 Oct
</div>

</div>
<div class='field field_text'>
<h3>
Measure Maintenance
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Annually</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Date of Next Anticipated Revision
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the measure.</p>
<p>This measure updates previous versions:</p>
<ul style="list-style-type: disc;">
    <li>Centers for Medicare &amp; Medicaid Services (CMS). Measure information form: delivered dose of hemodialysis above minimum. Baltimore (MD): Centers for Medicare &amp; Medicaid Services (CMS); 2015 Sep 25. 6 p. </li>
    <li>Centers for Medicare &amp; Medicaid Services (CMS). Measure justification form: delivered dose of hemodialysis above minimum. Baltimore (MD): Centers for Medicare &amp; Medicaid Services (CMS); 2015 Sep 25. 21 p. </li>
</ul></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Availability
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Source available from the <a href="https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/ESRDQIP/Downloads/CMS-ESRD-Measures-Manual-2017.pdf" title="Centers for Medicare &amp; Medicaid Services (CMS) Web site" target="_blank">Centers for Medicare &amp; Medicaid Services (CMS) Web site</a>.</p>
<p>For more information, refer to the <a href="https://dialysisdata.org/content/esrd-measures" title="Dialysis Data Web site">Dialysis Data Web site</a> or contact Casey Parrotte at the Kidney Epidemiology and Cost Center, The University of Michigan, 1415 Washington Heights, Suite 3645 SPHI, Ann Arbor, MI 48109-2029; Phone: 734-763-6611; Fax: 734-763-4004; Email: <a href="mailto:parrotte@med.umich.edu">parrotte@med.umich.edu</a>.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
NQMC Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NQMC summary was completed by ECRI Institute on May 14, 2010. The information was verified by the measure developer on June 14, 2010. This NQMC summary was retrofitted into the new template on June 27, 2011.</p>
<p>This NQMC summary was updated by ECRI Institute on December 5, 2014. The information was verified by the measure developer on February 6, 2015. </p>
<p>This NQMC summary was updated by ECRI Institute on July 14, 2016.</p>
<p>This NQMC summary was updated again by ECRI Institute on May 22, 2018. The information was not verified by the measure developer.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Copyright Statement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>No copyright restrictions apply.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Production
</h2>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Centers for Medicare & Medicaid Services (CMS). CMS ESRD measures manual for the 2017 performance period: final. Version 2.5. Baltimore (MD): Centers for Medicare & Medicaid Services (CMS); 2017 Oct 11. 168 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Disclaimer
</h2>
<div class='field field_text'>
<h3>
NQMC Disclaimer
</h3>
<div class='FieldValue'>
<p>The National Quality Measures Clearinghouseâ„¢ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.</p> 
<p>All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.</p> 
<p>Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the <a href="/help-and-about/summaries/inclusion-criteria">NQMC Inclusion Criteria</a>.</p> 
<p>NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding measure content are directed to contact the measure developer.</p>
</div>

</div>

</div>
</body></html>